Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07318233

Adaptive Self-Efficacy-Based AI Coaching for Cycling

The primary objective of this study is to evaluate whether adaptive, AI-delivered personalized self-efficacy-based AI coaching based on real-time physiological and performance feedback enhance indoor cycling power output during a 20-minute time trial compared to static affirmations and exercise-only control conditions.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-40 years
  • Recreationally active
  • Familiar with stationary cycling
  • Able to complete 20 minutes of vigorous cycling

Exclusion criteria

  • Cardiovascular, metabolic, or respiratory conditions
  • Medications affecting heart rate response
  • Lower extremity injury within past 3 months
  • Competitive cyclists (>10 hours cycling/week)
  • Pregnancy

Treatment and study plan

Group 1: Self-efficacy-based AI coaching

Behavioral

The Thompson Sampling contextual bandit algorithm, trained on Session 1 data, monitors performance continuously and evaluates every 5 seconds whether to deliver an affirmation. The policy is trained to maximize a multi-objective "efficacy-preserving performance" function that rewards:

  • Maintaining target power relative to rolling 30s/2min/5min baselines
  • Stabilizing short-horizon power variability (30s coefficient of variation)
  • Stabilizing heart-rate (HR) trajectory consistent with efficient pacing

The decision process considers:

  • Current power relative to 30-second, 2-minute, and 5-minute rolling averages
  • Power output variability (coefficient of variation over past 30 seconds)
  • Heart rate trajectory and cardiac drift patterns
  • Cadence stability and changes from baseline
  • Time elapsed and expected fatigue progression based on power-duration curve Self-efficacy-based AI coaching adapts to physiological measures (power and heart rate).

Group 2: Static AI Affirmations

Behavioral

Generic motivational messages delivered at fixed intervals (minutes 3, 6, 9, 12, 15, and 18) regardless of performance state. Messages follow the same complexity gradient based on elapsed time rather than individual response:

  • Minutes 3, 6: "You're building momentum with every pedal stroke-maintain this strong rhythm"
  • Minutes 9, 12: "Strong effort-push through this challenge"
  • Minutes 15, 18: "Final push-finish strong"

Primary outcomes

  1. Mean cycling power output during 20-minute time trial

    Time frame: Day 2

    Average cycling power output over the full 20-minute time trial. The outcome compares mean power between intervention arms (adaptive AI coaching vs. static affirmations vs. exercise-only control). Power is captured continuously via the cycling ergometer and summarized as the mean watts for each participant's trial.

Study contacts

Contact information is provided by the study sponsor or research team.

Anna Queiroz, Ph.D.

CONTACT

[email protected]

305-284-3752

Meshak Cole, B.S.

CONTACT

[email protected]

305-284-3752

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Registry information

Official study title

Adaptive Self-Efficacy-Based AI Coaching for Enhanced Indoor Cycling Performance: A Personalized Machine Learning Approach

Acronym: AI

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jan 5, 2026
Registry last updated
Mar 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.